Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
The role of TGF-beta in human cancer
Question 1 of 5
Topics
Head & Neck Cancers
Head & Neck Cancers
| Quiz | |
|---|---|
| Risk and prevalence of oropharyngeal cancers | Take Quiz |
| Oropharyngeal squamous cell carcinoma | Take Quiz |
| ATA Guidelines: Histopathologic evaluation of thyroidectomy samples in patients with DTC | Take Quiz |
| ATA Guidelines: Secretory products & morphological examination of MTC | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ATA Guidelines: Management of medullary thyroid | Take Quiz |
| Thyroid cancer trends in the United States | Take Quiz |
| DTC detection in obese and non-obese patients | Take Quiz |
| Staging: Papillary & follicular thyroid cancer | Take Quiz |
| Prognostic & risk factors of thyroid cancer | Take Quiz |
| Thyroid nodules & thyroid metastases | Take Quiz |
| Postoperative treatment of WDTC | Take Quiz |
| Recurrent thyroid cancer | Take Quiz |
| Thyroid gland malignancies: DTC, MTC, & ATC | Take Quiz |
| Surgical treatment: Stage III & IV papillary & follicular thyroid cancer | Take Quiz |
| The breast-thyroid cancer link | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| Impact of low iodine diet in DTC | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| Epidemiology & clinical presentation of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of parathyroid carcinoma | Take Quiz |
| Diagnosis & treatment of medullary thyroid cancer | Take Quiz |
| Thyroid cancer outcomes | Take Quiz |
| Clinical presentation & diagnosis of thyroid cancer | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Surgical treatment of primary stage differentiated thyroid cancer | Take Quiz |
| Treatment of differentiated thyroid cancer | Take Quiz |
| Types of differentiated thyroid cancer | Take Quiz |
CNS/Brain Cancer
CNS/Brain Cancer
| Quiz | |
|---|---|
| Types of gliomas | Take Quiz |
| Therapy for glioblastoma | Take Quiz |
| Glioblastoma: Reducing complications | Take Quiz |
| Glioblastoma & radiation therapy | Take Quiz |
| CNS malignancies: Laboratory studies, imaging, & molecular markers | Take Quiz |
| CNS malignancies: Management of complications | Take Quiz |
| Diffuse glioma: Risk factors | Take Quiz |
| In the News: Glioblastoma | Take Quiz |
| CNS malignancies: Epidemiology & pathophysiology | Take Quiz |
| CNS malignancies: Classification | Take Quiz |
Genitourinary Cancer
Genitourinary Cancer
| Quiz | |
|---|---|
| Prostate cancer in the US | Take Quiz |
| Prevalence of bladder cancer | Take Quiz |
| Non-muscle invasive bladder cancer | Take Quiz |
| Muscle invasive bladder cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| Testicular cancer: Staging & risk stratification | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| AHRQ Review: Management of renal masses & localized renal cancer | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Understanding urethral cancer | Take Quiz |
| Management of penile cancer | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Risk factors & clinical features of bladder cancer | Take Quiz |
| Histopathology of bladder cancer | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
| Serum tumor markers & testicular cancer | Take Quiz |
| Epidemiology & risk factors associated with testicular cancer | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| Clinical features and pathology of bladder cancer | Take Quiz |
| Treatment options for stage I & II RCC | Take Quiz |
| Treatment options for RCC | Take Quiz |
| RCC tumor characterization: Laboratory & imaging studies | Take Quiz |
| Genetic risk factors associated with RCC | Take Quiz |
| RCC subtypes | Take Quiz |
| Pathology & natural history of renal cancer | Take Quiz |
| RCC: Links & risk factors | Take Quiz |
| Clinical features & management of RCC | Take Quiz |
| Epidemiology & etiology of RCC | Take Quiz |
| Risk factors and pathology of prostate cancer | Take Quiz |
| Prostate cancer: Disease detection | Take Quiz |
| Diagnosis & prognosis of bladder cancer | Take Quiz |
| Classification of renal cell cancer | Take Quiz |
| Staging of testicular cancer | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
| Survival in advanced prostate cancer | Take Quiz |
| Understanding bladder cancer | Take Quiz |
| Treatment of prostate cancer | Take Quiz |
Immunotherapy
Immunotherapy
| Quiz | |
|---|---|
| Immune checkpoints & non-specific immunotherapies | Take Quiz |
| Monoclonal antibodies, adoptive cell therapy, & cytokines | Take Quiz |
| Targeting inhibitors of immune responses & nonspecific immunotherapy | Take Quiz |
| Active specific immunotherapy | Take Quiz |
| Therapeutic antibodies, vaccines & immune system modulators | Take Quiz |
| Passive cellular cancer immunotherapy | Take Quiz |
| Adoptive cell transfer & immune checkpoint modulators | Take Quiz |
| Types of immunotherapy | Take Quiz |
| Cancer preventive & cancer treatment vaccines | Take Quiz |
| Gene-expression profiling of tumors for immunotherapy | Take Quiz |
| Non-specific cancer immunotherapies & adjuvants | Take Quiz |
| Cancer cells & the immune system | Take Quiz |
| Cancer treatment: Monoclonal antibodies | Take Quiz |
| Forms of immunotherapy | Take Quiz |
| Breast cancer: Emerging immunotherapy options | Take Quiz |
| Immunotherapy & non-small cell lung cancer | Take Quiz |
| Immune checkpoints & their inhibitors | Take Quiz |
| Immune checkpoint inhibitors & tumors with mismatch repair deficiency | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| The role of TGF-beta in human cancer | Take Quiz |
| Immune checkpoint blockade: Tumor interferon signaling | Take Quiz |
| Efficacy of adoptive T-cell therapy | Take Quiz |
| Targeting the necrosome for cancer therapy | Take Quiz |
| Mechanisms involved in the tumor microenvironment | Take Quiz |
| B-cell receptor CD4+ T cells in cancer immunotherapy | Take Quiz |
| Improving T-cell potency via the CAR spacer | Take Quiz |
| ROR gamma agonists & antitumor immunity | Take Quiz |
| Role of B cell regulation in carcinogenesis | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 2 | Take Quiz |
| Cancer therapies: Vaccine adjuvants, Part 1 | Take Quiz |
| Validation of biomarkers to predict cancer immunotherapy response | Take Quiz |
| Immune checkpoint modulators & immune cell therapy | Take Quiz |
| Function of Hippo pathway kinases in cancer | Take Quiz |
| Cancer immunotherapy: Immune checkpoint blockers | Take Quiz |
| Cancer immunotherapy target: Wnt/β-catenin signaling in dendritic cells | Take Quiz |
| Understanding oncolytic viruses | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 2 | Take Quiz |
| Cancer immunotherapy: Producer T cells – Part 1 | Take Quiz |
| Cancer immunotherapy: Oncolytic viruses | Take Quiz |
| Immune checkpoint blockade in cancer therapy | Take Quiz |
| Cancer immunotherapy: Targeting microRNAs | Take Quiz |
| Cancer immunotherapy: Role of Tcon & Treg | Take Quiz |
| IL-24 in immunotherapy | Take Quiz |
| Key omics modalities for precision oncology | Take Quiz |
| CAR T cell therapy in cancer treatment | Take Quiz |
| Categories of tumor antigens | Take Quiz |
| Checkpoint blockade therapy: Immune monitoring assays | Take Quiz |
| Cancer immunotherapy: TCR design | Take Quiz |
| Novel approaches to cancer immunotherapy | Take Quiz |
| Principles of cancer immunotherapy | Take Quiz |
| PD-1/PD-L1 immune checkpoint blockade therapy | Take Quiz |
| Approaches to cancer immunotherapy | Take Quiz |
| Oncolytic viruses as immunotherapy | Take Quiz |
| Cancer immunotherapy mechanisms, advantages, & disadvantages | Take Quiz |
| Immunotherapy in MIS CRC | Take Quiz |
| Cancer immunotherapy: CAR design | Take Quiz |
| Precision immunotherapy | Take Quiz |
| Molecular mechanisms of immune avoidance | Take Quiz |
| Immunotherapy for brain tumors | Take Quiz |
| Adenosine in the tumor microenvironment | Take Quiz |
| The role of TILs and MILs in cancer therapy | Take Quiz |
| Leveraging the antigenic identity of tumors | Take Quiz |
| Advances in cancer immunotherapy | Take Quiz |
| Novel technologies for cancer immunotherapy | Take Quiz |
| Understanding cancer immunology & immunotherapy | Take Quiz |
| Personalized cancer immunotherapy: Novel immune monitoring | Take Quiz |
| Understanding cancer immunotherapy | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
| Quiz | |
|---|---|
| Cachexia in cancer | Take Quiz |
| HCT & non-HCT cancer survivors: Morbidity & mortality | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| Fertility preservation among cancer patients | Take Quiz |
Gastroenterology
Gastroenterology
| Quiz | |
|---|---|
| Treatment for GI carcinoid tumors | Take Quiz |
| Treatment approaches for pancreatic cancer | Take Quiz |
| Pancreatic cancer prognosis & overall survival | Take Quiz |
| Diagnostics for GI carcinoids: Biochemical markers & imaging | Take Quiz |
| Cellular classification of pancreatic cancer | Take Quiz |
| Duodenal carcinoids: Clinical features | Take Quiz |
| Appendiceal & colorectal carcinoids | Take Quiz |
| Pancreatic cancer: Clinical features & diagnosis | Take Quiz |
| Jejunal and ileal carcinoids | Take Quiz |
| GI carcinoid tumors: Genetics & carcinoid syndrome | Take Quiz |
| PDA complications & heritable risk factors | Take Quiz |
| GI carcinoid tumors: Anatomy & histopathology | Take Quiz |
| Cellular classification & staging of adult primary liver cancer | Take Quiz |
| HCC: Prognosis, diagnostic imaging & liver biopsy | Take Quiz |
| HCC: Risk factors & diagnosis | Take Quiz |
| Pancreatic adenocarcinoma: Staging, radiographic & laboratory evaluation | Take Quiz |
| Heritable risk factors for pancreatic adenocarcinoma | Take Quiz |
| Pancreatic adenocarcinoma: Imaging studies | Take Quiz |
| Pancreatic adenocarcinoma: Features, diagnosis, & management | Take Quiz |
| Neuroendocrine tumors: Diagnosis | Take Quiz |
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Pathophysiology & prognosis of PDA | Take Quiz |
| Staging, radiographic, & laboratory evaluation of PDA | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
Gynecologic Cancer
Gynecologic Cancer
| Quiz | |
|---|---|
| Uterine sarcoma treatment | Take Quiz |
| Uterine sarcoma types & prognosis | Take Quiz |
| Endometrial cancer risk, signs, & symptoms | Take Quiz |
| Endometrial cancer: Prognostic factors | Take Quiz |
| Ovarian epithelial cancer: Incidence & mortality | Take Quiz |
| Ovarian epithelial cancer diagnostic & staging evaluation | Take Quiz |
| Ovarian epithelial cancer: Clinical presentation & risk | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| Subtypes of endometrial cancer | Take Quiz |
| Screening & serum biomarkers for EOC | Take Quiz |
| Prevention of EOC with RRSO | Take Quiz |
| Diagnosis, evaluation, and treatment of EOC | Take Quiz |
| Diagnosis & screening of endometrial cancer | Take Quiz |
| Risk factors & screening for endometrial cancer | Take Quiz |
| Prevention & screening of ovarian cancer | Take Quiz |
| EOC pathology | Take Quiz |
| Nodal spread & endometrial cancer | Take Quiz |
Rare Diseases
Rare Diseases
| Quiz | |
|---|---|
| Treatment approaches for pancreatic cancer | Take Quiz |
| Pancreatic cancer prognosis & overall survival | Take Quiz |
Oncology
Oncology
| Quiz | |
|---|---|
| Active specific immunotherapy | Take Quiz |
| CDC Report: Cancer & obesity | Take Quiz |
| ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
| ACOS Guidelines: Biomarkers & early-stage invasive breast cancer | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| Breast cancer imaging techniques | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| PD-based cancer immunotherapy | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| 2017 ASCO Quality Symposium highlights | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
| ASCO Guidelines: HER2 testing in BC | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Pediatrics
Pediatrics
| Quiz | |
|---|---|
| Wilms tumor signs, symptoms, & diagnosis | Take Quiz |
Sarcoma & GIST
Sarcoma & GIST
| Quiz | |
|---|---|
| Sarcoma: Laboratory & imaging studies | Take Quiz |
| Sarcoma clinical features & risk | Take Quiz |
| Sarcoma & GIST pathophysiology | Take Quiz |
| Therapies for sarcoma & GIST | Take Quiz |
| Sarcoma: Importance of histology | Take Quiz |
| Sarcoma imaging: STS or benign processes? | Take Quiz |
| High-risk sarcomas & chemoradiation | Take Quiz |
| Sarcoma: Radiotherapy benefits | Take Quiz |
| Sarcoma: Radiation and surgical options | Take Quiz |
| Stages of sarcoma | Take Quiz |
| Diagnosing sarcoma | Take Quiz |
| Sarcoma: Disease overview | Take Quiz |
Metastatic Breast Cancer
Metastatic Breast Cancer
| Quiz | |
|---|---|
| Managing HER2-positive breast cancer | Take Quiz |
| Management of metastatic breast cancer | Take Quiz |
| Metastatic breast cancer: Prognosis | Take Quiz |
| Management of metastatic breast cancer in pre- and post-menopausal patients | Take Quiz |
| Metastatic breast cancer: Reducing complications | Take Quiz |
| Metastatic breast cancer: Laboratory & radiology evaluation | Take Quiz |
| Metastatic breast cancer & endocrine therapy | Take Quiz |
| Metastatic breast cancer: Chemotherapy | Take Quiz |
| Treatment of HR positive and HER2 negative tumors | Take Quiz |
| Metastatic breast cancer: Pathology & molecular markers | Take Quiz |
| Features of metastatic breast cancer | Take Quiz |
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
Neuro-oncology
Neuro-oncology
| Quiz | |
|---|---|
| Therapy for glioblastoma | Take Quiz |
| Glioblastoma & radiation therapy | Take Quiz |
| CNS malignancies: Management of complications | Take Quiz |
| Diffuse glioma: Risk factors | Take Quiz |
Breast Cancer
Breast Cancer
| Quiz | |
|---|---|
| Breast cancer diagnosis & management | Take Quiz |
| ASCO Guideline: SLN biopsy & early-stage breast cancer | Take Quiz |
| ASCO/ASTRO/SSO Guideline: Postmastectomy radiotherapy | Take Quiz |
| Management of metastatic breast cancer | Take Quiz |
| Breast cancer classification & management | Take Quiz |
| Breast cancer risk factors | Take Quiz |
| Metastatic breast cancer: Laboratory & radiology evaluation | Take Quiz |
| Metastatic breast cancer & endocrine therapy | Take Quiz |
| ACOS Guidelines: Biomarkers & early-stage invasive breast cancer | Take Quiz |
| Metastatic breast cancer: Chemotherapy | Take Quiz |
| Treatment of HR positive and HER2 negative tumors | Take Quiz |
| Metastatic breast cancer: Pathology & molecular markers | Take Quiz |
| Features of metastatic breast cancer | Take Quiz |
| Stage 0 breast cancer: Risk factors & management | Take Quiz |
| Stage 0 breast cancer: DCIS & LCIS | Take Quiz |
| Breast cancer imaging techniques | Take Quiz |
| Breast cancer: Types of surgery | Take Quiz |
| Circulating tumor cell clusters & metastatic breast cancer outcomes | Take Quiz |
| Breast cancer with leptomeningeal metastasis: Characteristics & outcomes | Take Quiz |
| De novo metastatic breast cancer: Occurrence & outcome by subtype | Take Quiz |
| Metastatic breast cancer: Adapting to changes during treatment | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| HER2 overexpression | Take Quiz |
| Breast cancer: Tissue diagnosis & imaging studies | Take Quiz |
| Early & advanced breast cancer: Use of imaging in evaluation & follow-up | Take Quiz |
| Breast cancer: Circulating tumor cells | Take Quiz |
| Metastatic breast cancer with ESR1 mutation: Clinical management considerations | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
| ASCO Guidelines: HER2 testing in BC | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| ASCO/CAP Guidelines: HER2 & FISH testing | Take Quiz |
| Factors related to breast cancer surgery choices | Take Quiz |
| Obesity & postmenopausal breast cancer risk | Take Quiz |
| Breast conservation & neoadjuvant therapy | Take Quiz |
| Oophorectomy & breast cancer | Take Quiz |
Leukemia, Myelodysplasia, Transplantation
Leukemia, Myelodysplasia, Transplantation
| Quiz | |
|---|---|
| GVHD after donor lymphocyte infusion | Take Quiz |
| Donor lymphocyte infusion: Indications | Take Quiz |
| Testing & mutational analysis in chronic myeloid leukemia | Take Quiz |
Melanoma
Melanoma
| Quiz | |
|---|---|
| Melanoma management | Take Quiz |
| Melanoma: Pattern recognition & prevalence | Take Quiz |
| Conditions that mimic melanoma | Take Quiz |
| Diagnosing melanoma | Take Quiz |
| Etiology & clinical presentation of BCC | Take Quiz |
| Etiology & presentation of squamous cell carcinoma | Take Quiz |
| Uveal choroidal melanoma | Take Quiz |
| Management of metastatic melanoma | Take Quiz |
| Adjuvant treatment of melanoma | Take Quiz |
| Melanoma early diagnosis & staging | Take Quiz |
| Melanoma risk factors | Take Quiz |
| Melanoma: Epidemiology & etiology | Take Quiz |
| Clinical features of melanoma | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| CDC Report: Cancer & obesity | Take Quiz |
| ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
| ASCO Guidelines: Primary prevention of cervical cancer | Take Quiz |
| ASCO/CCO Guidelines: Prostate cancer & brachytherapy | Take Quiz |
| ASCO Guidelines: Cancer treatment & cardiac dysfunction risk | Take Quiz |
| 2017 ASCO Quality Symposium highlights | Take Quiz |
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| ATA Guidelines: Intraoperative voice and parathyroid management & follow-up in patients with DTC | Take Quiz |
| ATA Guidelines: Voice and parathyroid issues in DTC | Take Quiz |
| ASCO Guidelines: Integrating palliative care | Take Quiz |
| ATA Guidelines: Lymph node dissection & DTC | Take Quiz |
| ASCO Guidelines: Cervical cancer screening | Take Quiz |
| AUA-SUO Guidelines: BCG relapse & salvage regimens in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: TURBT/Repeat resection & intravesical therapy in bladder cancer | Take Quiz |
| AUA-SUO Guidelines: Urine markers & TURBT/Repeat resection in bladder cancer | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA-SUO Guidelines: Diagnosis of non-muscle invasive bladder cancer | Take Quiz |
| ASCO Guidelines: Adjuvant therapy selection & early-stage breast cancer | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| ASCO Guidelines: Endocrine therapy & HR-positive metastatic breast cancer | Take Quiz |
| ASCO Guidelines: HR-positive breast cancer & adjuvant endocrine therapy | Take Quiz |
| ASCO/SSO/ASTRO Consensus Guideline: Margins for breast-conserving surgery with WBRT in DCIS | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 1 | Take Quiz |
| ASCO Guidelines: HER2 testing in BC | Take Quiz |
| ASCO Guidelines: Use of biomarkers to guide therapy in early-stage invasive BC--Part 2 | Take Quiz |
| AUA Guideline: Follow-up for clinically localized renal neoplasms | Take Quiz |
| ATA Guidelines: Surgery for thyroid cancer | Take Quiz |
| ATA Guidelines: Preoperative neck ultrasound & laboratory tests for DTC | Take Quiz |
| ATA Guidelines: Use of CT, MRI, and PET for neck imaging | Take Quiz |
| ATA Guidelines: Initial management of DTC & neck imaging | Take Quiz |
| Bowel preparation before colonoscopy | Take Quiz |
| Bowel cleansing for colonoscopy: Diet, regimens, & rating | Take Quiz |
| Colonoscopy surveillance after screening & polypectomy | Take Quiz |
| Endoscopy in the staging & management of CRC | Take Quiz |
| Risk factors & prostate cancer | Take Quiz |
| ASCO/ACS: Prostate cancer survivorship care guidelines | Take Quiz |
Preventive Care
Preventive Care
| Quiz | |
|---|---|
| CDC Report: Cancer & obesity | Take Quiz |
Lung Cancer
Lung Cancer
| Quiz | |
|---|---|
| ASCO Guideline: Systemic therapy for stage IV NSCLC | Take Quiz |
| Non-small cell lung cancer: Thoracic symptoms, metastatic disease, & paraneoplastic syndrome | Take Quiz |
| Non-small cell lung cancer: Subtypes & management | Take Quiz |
| Lung cancer: Risk factors, diagnosis, & screening | Take Quiz |
| NSCLC: Delayed chemo & survival after surgery | Take Quiz |
| EGFR tyrosine kinase inhibition & lung cancer | Take Quiz |
| Lung cancer: Molecular profiling | Take Quiz |
| Lung cancer: The role of imaging studies & chest CT | Take Quiz |
| Understanding lung cancer | Take Quiz |
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
| Pathology & clinical presentation of small cell lung cancer | Take Quiz |
| Staging & imaging of small cell lung cancer | Take Quiz |
| Treatment of stage IIIA NSCLCs | Take Quiz |
| RAS mutations in NSCLC by Kevin Wood, MD | Take Quiz |
| Treatment of early-stage NSCLCs | Take Quiz |
| Clinical evaluation of single pulmonary nodules | Take Quiz |
| NSCLC risk and subtypes | Take Quiz |
| Lung cancer pathology | Take Quiz |
GI Oncology
GI Oncology
| Quiz | |
|---|---|
| HCC: Risk factors & diagnosis | Take Quiz |
| Pancreatic adenocarcinoma: Staging, radiographic & laboratory evaluation | Take Quiz |
| Heritable risk factors for pancreatic adenocarcinoma | Take Quiz |
| Pancreatic adenocarcinoma: Imaging studies | Take Quiz |
| Pancreatic neuroendocrine tumors: Pathogenesis & prognostic factors | Take Quiz |
| Colorectal cancer & endoscopic resection | Take Quiz |
| USPSTF Guidelines: Update on CRC screening | Take Quiz |
| Risk factors & screening for gastric cancers | Take Quiz |
| Risk factors associated with PDA | Take Quiz |
| Diagnostic laparoscopy & management of PDA | Take Quiz |
| Management of PDA & metastatic disease | Take Quiz |
| Treatment of esophageal cancer | Take Quiz |
| Pathology & staging workup of esophageal cancer | Take Quiz |
| Diagnosing PDA: Imaging & aspiration/biopsy | Take Quiz |
| Clinical presentation & diagnosis of esophageal cancer | Take Quiz |
| Epidemiology & etiology of esophageal cancer | Take Quiz |
| Gastric cancer prevention | Take Quiz |
| Rectal cancer: Neoadjuvant therapy vs surgery | Take Quiz |
| Adenoma detection rates in CRC | Take Quiz |
| Preoperative chemotherapy & colorectal cancer | Take Quiz |
| Familial adenomatous polyposis & CRC | Take Quiz |
| Screening of CRC | Take Quiz |
| Colonoscopy: Optimizing adequate bowel cleansing | Take Quiz |
| ASCO Guidelines: Surveillance protocol for survivors of CRC | Take Quiz |
| Epidemiology & risk factors of CRC | Take Quiz |
| Genetic evaluation & management of Lynch syndrome | Take Quiz |
| Laparoscopic resection vs surgery for rectal cancer | Take Quiz |
| Risk factors & prognosis of rectal cancer | Take Quiz |
| Understanding hereditary CRC syndromes: Part 2 | Take Quiz |
| Colorectal cancer screening: Flexible sigmoidoscopy | Take Quiz |
Nonmelanoma Skin Cancer
Nonmelanoma Skin Cancer
| Quiz | |
|---|---|
| Non-melanoma skin cancer: Basal cell carcinoma & squamous cell carcinoma | Take Quiz |
| First FDA-approved Merkel cell carcinoma treatment | Take Quiz |
Renal Cell Carcinoma
Renal Cell Carcinoma
| Quiz | |
|---|---|
| ASCO Guidelines: Management of renal cell masses | Take Quiz |
| RCC subtypes: Risk factors, clinical findings, & imaging | Take Quiz |
| Common RCC subtypes | Take Quiz |
| AUA Guideline: Ablation procedures & RCC follow-up | Take Quiz |
| AUA Guideline: RCC surgical follow-up & active surveillance | Take Quiz |
| Staging & surveillance of RCC | Take Quiz |
| Minimally invasive surgery for RCC | Take Quiz |
| Pathophysiology & prognosis of RCC | Take Quiz |
| Unique patient categories in RCC | Take Quiz |
| Management of localized RCC | Take Quiz |
Case-Based Quizzes
Case-Based Quizzes
| Quiz | |
|---|---|
| Advanced & previously treated NSCLC: The OAK & POPLAR trials by Bobby Daly, MD, MBA | Take Quiz |
| PD-L1-Positive NSCLC and KEYNOTE-024, by Bobby Daly, MD, MBA | Take Quiz |
| Quiz | |
|---|---|
| Screening & prevention of head & neck cancer | Take Quiz |
| Prognosis of head & neck cancer | Take Quiz |
| Epidemiology & risk factors associated with head & neck cancer | Take Quiz |
| Diagnosis & staging of head & neck cancer | Take Quiz |
| Diagnosis & management of infectious disease syndromes | Take Quiz |
| Evaluation of a neutropenic patient with fever | Take Quiz |
| Myelodysplastic syndrome | Take Quiz |
| Therapeutic approaches to myelodysplastic syndrome | Take Quiz |
Mixed Topics
Mixed Topics
| Quiz | |
|---|---|
| Empirical antifungal therapy of fever & neutropenia | Take Quiz |
| Syndromes of fever during neutropenia | Take Quiz |
| Quality Care in Oncology by Bobby Daly, MD, MBA | Take Quiz |
| Empirical antibiotic therapy of fever & neutropenia | Take Quiz |
| Fertility preservation among cancer patients | Take Quiz |
